⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTRS News
Viatris Inc. Common Stock
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
prnewswire.com
VTRS
Form 8-K
sec.gov
VTRS
U.S. FDA Approves INQOVI ® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
businesswire.com
VTRS
Insulin Aspart Market Shifts Toward Access and Biosimilar Competition as Rapid-Acting Insulin Remains Essential for Mealtime Glucose Control
accessnewswire.com
NVO
SNY
VTRS
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
prnewswire.com
VTRS
Form 8-K
sec.gov
VTRS
Viatris Reports First-Quarter 2026 Financial Results
prnewswire.com
VTRS
American Kidney Fund and AKF Ambassadors on Capitol Hill for Annual AKF Kidney Action Summit
globenewswire.com
ALNY
AMGN
ARDX
AZN
BIIB
CDTX
CSL
GSK
NVS
PFE
SNY
VRTX
VTRS
Viatris Announces Quarterly Dividend
prnewswire.com
VTRS
Form 8-K
sec.gov
EW
VTRS